TRAVIS SENOR: Open Payments
NPI 1316602246 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,403 in 231 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $332 · 2025 $3,403
Food & beverage: $3,294Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 59 | $856 |
| Teva Pharmaceuticals USA, Inc. | 16 | $310 |
| Vanda Pharmaceuticals Inc. | 23 | $304 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $246 |
| Janssen Pharmaceuticals, Inc | 12 | $224 |
| Otsuka America Pharmaceutical, Inc. | 13 | $195 |
| Alkermes, Inc. | 12 | $194 |
| Supernus Pharmaceuticals, Inc. | 28 | $186 |
| Collegium Pharmaceutical, Inc. | 14 | $161 |
| Axsome Therapeutics, Inc. | 12 | $152 |
Products named: VRAYLAR, HETLIOZ, CAPLYTA, SPRAVATO, ARISTADA, Qelbree, REXULTI, Jornay PM.
Industry payments across NC — which companies pay providers there.
